News FDA ramps up unannounced inspections of foreign facilities Trump orders the FDA to ease the commissioning of domestic manufacturing facilities, as the regulator announces more unannounced foreign inspections.
News EU proposes legislation to bolster medicines supply chain The EU has proposed legislation to safeguard the supply of critical medicines but pharma and patient groups are concerned about the details.
News Lilly unveils $27bn reshoring drive around four new plants Trump threatened tariffs if businesses do not reshore production to the US - and Lilly has now revealed a $27bn spend on new domestic facilities.
R&D Reshoring the UK pharmaceutical supply chain for future resi... Questions of supply chain security and resiliency have been growing in recent years.
R&D Ben Sidders on integrating causality in AI for R&D success Ben Sidders, chief scientific officer at Biorelate, discusses leveraging advanced data science methods to transform the focus and impact of R&D.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face